The Clinical Safety and Pharmacovigilance Track will feature current practices and new developments that minimize risks to patients of investigational and marketed medical products.

At the conclusion of this meeting, participants should be able to:
• Discuss a broad array of concepts and tools(traditional and new) that support participants’ pursuit of excellence in patient safety, for both investigational and marketed products

**Please note workshops that were made available during the Annual Meeting included attendee interactivity. Due to such format, audio recordings may not be available.